Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'Home Alone' actor Joe Pesci said 'no' to this stunt until he saw a 9-year-old girl do it, says director Chris Columbus - 2A Timeline of Rising Antisemitism in Australia
- 3Novartis eyes more bolt-on acquisitions, CEO says
- 4Popular Japanese Hotel Chain Now Lets You Show Up With Just Your Passport
- 5The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- All that You Really want to Be familiar with Dental Inserts Facilities
- Oil, energy and food: Which countries in Europe are most exposed to higher food prices?
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
- 7 Odd Apparatuses to Make Your Party Stick Out!
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- Early diagnosis leads King Charles to scale back cancer treatment in the new year
- Key takeaways from Sen. Bill Cassidy's interview on 'Face the Nation' with Margaret Brennan
- Northern lights chances rise for Christmas as space weather remains unsettled
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
